Dr. Liang Zhang 张亮
Chief Physician
Department of Thoracic Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of lung cancer, esophageal cancer, and mediastinal tumors. Expertise in single-port thoracoscopic surgery, thoraco-laparoscopic combined treatment for esophageal cancer, extended radical resection for lung cancer, and sleeve reconstruction of trachea, bronchi, and vessels.
Dr. Zhang is Director of the Sixth Thoracic Surgery Ward at Liaoning Cancer Hospital & Institute and a master’s supervisor at several universities. In 2014 and 2016, Dr. Zhang visited the Prince of Wales Hospital (Hong Kong) and Careggi Hospital (Italy). The department describes its minimally invasive esophageal cancer treatment as leading in China.
Professional roles
- Member, Asian Society of Cardiovascular and Thoracic Surgery
- Member, Case Management Committee, China Anti-Cancer Association
- Standing Committee Member, Thoracic Surgery Professional Committee, China Medicine Education Association
- Editorial Board Member, Journal of Chronic Diseases
Name order: in Chinese the family name comes first (Zhang Liang). Papers usually list the name as Liang Zhang or Zhang L.
Selected publications
35 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Med, 2026 (senior author): The surgical approach strategies in the treatment of anterior mediastinal tumors. PubMed 41918237
- Mol Cancer Res, 2026 (senior author): ID4 Suppresses Proliferation and Macrophage Polarization in Esophageal Carcinoma through Interaction with TCF4. PubMed 41770101
- Front Oncol, 2026 (senior author): Correction: Factors associated with secondary thoracotomy for hemostasis following lung surgery: a retrospective analysis. PubMed 41836221
- J Thorac Oncol, 2025 (senior author): Disparities in Locoregional Relapse Across Tumor Sites After Segmentectomy. PubMed 41203383
- Front Oncol, 2025 (senior author): Factors associated with secondary thoracotomy for hemostasis following lung surgery: a retrospective analysis. PubMed 40900802
- Cancer Immunol Immunother, 2025 (senior author): SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells. PubMed 39891717
- Crit Rev Eukaryot Gene Expr, 2025 (senior author): Mechanism of Curcumin Inhibition of Malignant Progression of Lung Cancer Cells by Regulating Ferroptosis via the NRF2/HMOX1 Pathway. PubMed 40530967
- Int Immunopharmacol, 2024 (senior author): FOXF2 suppressed esophageal squamous cell carcinoma by reducing M2 TAMs via modulating RNF144A-FTO axis. PubMed 39447407
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion